141 related articles for article (PubMed ID: 30867339)
21. Targeting the mTOR signaling network for Alzheimer's disease therapy.
Wang C; Yu JT; Miao D; Wu ZC; Tan MS; Tan L
Mol Neurobiol; 2014 Feb; 49(1):120-35. PubMed ID: 23853042
[TBL] [Abstract][Full Text] [Related]
22. FTO is involved in Alzheimer's disease by targeting TSC1-mTOR-Tau signaling.
Li H; Ren Y; Mao K; Hua F; Yang Y; Wei N; Yue C; Li D; Zhang H
Biochem Biophys Res Commun; 2018 Mar; 498(1):234-239. PubMed ID: 29501742
[TBL] [Abstract][Full Text] [Related]
23. Dysregulated mTOR-dependent signaling in neurodegeneration or carcinogenesis: implication for Alzheimer's disease and brain tumors.
Wang S; Wu J; Nie SD; Bereczki E; Pei JJ
J Alzheimers Dis; 2013; 37(3):495-505. PubMed ID: 23948902
[TBL] [Abstract][Full Text] [Related]
24. cPKCγ-mediated down-regulation of UCHL1 alleviates ischaemic neuronal injuries by decreasing autophagy via ERK-mTOR pathway.
Zhang D; Han S; Wang S; Luo Y; Zhao L; Li J
J Cell Mol Med; 2017 Dec; 21(12):3641-3657. PubMed ID: 28726275
[TBL] [Abstract][Full Text] [Related]
25. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
Caccamo A; Magrì A; Medina DX; Wisely EV; López-Aranda MF; Silva AJ; Oddo S
Aging Cell; 2013 Jun; 12(3):370-80. PubMed ID: 23425014
[TBL] [Abstract][Full Text] [Related]
26. MircoRNA-126-5p inhibits apoptosis of endothelial cell in vascular arterial walls via NF-κB/PI3K/AKT/mTOR signaling pathway in atherosclerosis.
Jia W; Liu J; Tian X; Jiang P; Cheng Z; Meng C
J Mol Histol; 2022 Feb; 53(1):51-62. PubMed ID: 34981408
[TBL] [Abstract][Full Text] [Related]
27. Artemisinin Attenuated Atherosclerosis in High-Fat Diet-Fed ApoE-/- Mice by Promoting Macrophage Autophagy Through the AMPK/mTOR/ULK1 Pathway.
Cao Q; Du H; Fu X; Duan N; Liu C; Li X
J Cardiovasc Pharmacol; 2020 Apr; 75(4):321-332. PubMed ID: 31895870
[TBL] [Abstract][Full Text] [Related]
28. PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease.
O' Neill C
Exp Gerontol; 2013 Jul; 48(7):647-53. PubMed ID: 23470275
[TBL] [Abstract][Full Text] [Related]
29. Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease.
Ma T; Hoeffer CA; Capetillo-Zarate E; Yu F; Wong H; Lin MT; Tampellini D; Klann E; Blitzer RD; Gouras GK
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862226
[TBL] [Abstract][Full Text] [Related]
30. Expression of miRNA-155 in carotid atherosclerotic plaques of apolipoprotein E knockout (ApoE
Ma J; Yang S; Ma A; Pan X; Wang H; Li N; Liu S; Wu M
Int Immunopharmacol; 2017 May; 46():70-74. PubMed ID: 28273556
[TBL] [Abstract][Full Text] [Related]
31. Oxidative Stress and Decreased Mitochondrial Superoxide Dismutase 2 and Peroxiredoxins 1 and 4 Based Mechanism of Concurrent Activation of AMPK and mTOR in Alzheimer's Disease.
Majd S; Power JHT
Curr Alzheimer Res; 2018; 15(8):764-776. PubMed ID: 29473507
[TBL] [Abstract][Full Text] [Related]
32. Increased mTORC1 activity contributes to atherosclerosis in apolipoprotein E knockout mice and in vascular smooth muscle cells.
Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
Int J Cardiol; 2013 Oct; 168(6):5450-3. PubMed ID: 23972959
[No Abstract] [Full Text] [Related]
33. Endothelial epithelial sodium channel involves in high-fat diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice.
Niu N; Yang X; Zhang BL; Liang C; Zhu D; Wang QS; Cai YX; Yang YC; Ao X; Wu MM; Zhang ZR
Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165989. PubMed ID: 33065235
[TBL] [Abstract][Full Text] [Related]
34. Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer's disease: an adrenergic approach.
Li S; Wang C; Wang Z; Tan J
Aging (Albany NY); 2021 Sep; 13(17):21791-21806. PubMed ID: 34479211
[TBL] [Abstract][Full Text] [Related]
35. Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease.
Kalaria RN
Neurobiol Aging; 2009 Sep; 30(9):1512-4. PubMed ID: 18187235
[TBL] [Abstract][Full Text] [Related]
36. Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer's disease.
Sun YX; Ji X; Mao X; Xie L; Jia J; Galvan V; Greenberg DA; Jin K
J Alzheimers Dis; 2014; 38(2):437-44. PubMed ID: 23979023
[TBL] [Abstract][Full Text] [Related]
37. The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).
Yang H; Hou T; Wang W; Luo Y; Yan F; Jia J
J Alzheimers Dis; 2018; 62(4):1609-1621. PubMed ID: 29614686
[TBL] [Abstract][Full Text] [Related]
38. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
[TBL] [Abstract][Full Text] [Related]
39. Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer's disease.
Franco R; Martínez-Pinilla E; Navarro G; Zamarbide M
Prog Neurobiol; 2017; 149-150():21-38. PubMed ID: 28189739
[TBL] [Abstract][Full Text] [Related]
40. Deletion of the Mir-106b~ 25 MicroRNA cluster attenuates atherosclerosis in Apolipoprotein E knockout mice.
Semo J; Chernin G; Jonas M; Shimoni S; George J
Lipids Health Dis; 2019 Dec; 18(1):208. PubMed ID: 31796057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
